Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nuvo Pharmaceuticals Inc (NRI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5160
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver drugs topically into and through the skin to the specific site of activity. Nuvo’s pennsaid and transdermal drug carriers are used for the treatment of osteoarthritis of the knee; and heated lidocaine or tetracaine patch, is a topical patch that combines lidocaine, tetracaine and heat using proprietary controlled heat-assisted drug delivery technology. The company operates through its manufacturing facility located in Varennes, Quebec. It markets its products through a network of distributors. Nuvo Pharmaceuticals is headquartered in Mississauga, Ontario, Canada.

Nuvo Pharmaceuticals Inc (NRI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Nuvo Pharma to Acquire Pharma Business from Aralez Pharma for USD110 Million 12
Nuvo Pharma Acquires Ex-US Rights to Resultz from Piedmont Pharma for USD7 Million 14
Nuvo Research Reacquires Pennsaid Rights from Paladin Labs 15
Partnerships 16
Nuvo Research Enters Into Co-Development Agreement With Ferndale Labs And Contract Research Organization 16
Nuvo Research Enters Into Distribution Agreement With NovaMedica For Pennsaid 17
Licensing Agreements 18
Gebro Pharma Enters into Licensing Agreement with Nuvo Pharma 18
Sayre Therapeutics Enters into Licensing Agreement with Nuvo Pharma 19
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 20
Nuvo Research Enters Into Licensing Agreement With Paladin Labs For Synera 21
Equity Offering 22
Nuvo Research Completes Private Placement Of Units For US$2.8 Million 22
Asset Transactions 23
Horizon Pharma Acquires US Rights to Pennsaid 2% from Nuvo Research for USD45 Million 23
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 25
Tioga Acquires HTE Formulation Patents from Nuvo Research 26
Nuvo Pharmaceuticals Inc – Key Competitors 27
Nuvo Pharmaceuticals Inc – Key Employees 28
Nuvo Pharmaceuticals Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 02, 2018: Nuvo Pharmaceuticals announces 2018 second quarter results 30
May 10, 2018: Nuvo Pharmaceuticals Announces 2018 First Quarter Results 32
Mar 23, 2018: Nuvo Pharmaceuticals Announces 2017 Fourth Quarter and Year-End Results 34
Nov 01, 2017: Nuvo Pharmaceuticals Announces 2017 Third Quarter Results 36
Aug 09, 2017: Nuvo Pharmaceuticals Announces 2017 Second Quarter Results 39
May 10, 2017: Nuvo Pharmaceuticals Announces 2017 First Quarter Results 42
Mar 01, 2017: Nuvo Pharmaceuticals Announces 2016 Year-End and Fourth Quarter Results 44
Corporate Communications 47
Nov 22, 2017: Nuvo Pharmaceuticals Announces Appointment of Jesse Ledger as President & Chief Executive Officer 47
Legal and Regulatory 48
Aug 20, 2018: Nuvo Pharmaceuticals announces extension of exclusivity period with Aralez and Deerfield 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuvo Pharma to Acquire Pharma Business from Aralez Pharma for USD110 Million 12
Nuvo Pharma Acquires Ex-US Rights to Resultz from Piedmont Pharma for USD7 Million 14
Nuvo Research Reacquires Pennsaid Rights from Paladin Labs 15
Nuvo Research Enters Into Co-Development Agreement With Ferndale Labs And Contract Research Organization 16
Nuvo Research Enters Into Distribution Agreement With NovaMedica For Pennsaid 17
Gebro Pharma Enters into Licensing Agreement with Nuvo Pharma 18
Sayre Therapeutics Enters into Licensing Agreement with Nuvo Pharma 19
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 20
Nuvo Research Enters Into Licensing Agreement With Paladin Labs For Synera 21
Nuvo Research Completes Private Placement Of Units For US$2.8 Million 22
Horizon Pharma Acquires US Rights to Pennsaid 2% from Nuvo Research for USD45 Million 23
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 25
Tioga Acquires HTE Formulation Patents from Nuvo Research 26
Nuvo Pharmaceuticals Inc, Key Competitors 27
Nuvo Pharmaceuticals Inc, Key Employees 28
Nuvo Pharmaceuticals Inc, Subsidiaries 29

List of Figures
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tivoli A/S
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sunquest Information Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sunquest Information Systems Inc (Sunquest), a subsidiary of Roper Technologies, is a healthcare information technology (IT) company that provides diagnostic informatics solutions to laboratories and healthcare organizations worldwide. The company offers laboratory informatics such as labora …
  • Instituto Costarricense de Electricidad:電力:M&Aディール及び事業提携情報
    Summary Instituto Costarricense de Electricidad (ICE) is an autonomous institution of the Government of Costa Rica that provides electricity and telecommunications services. The company generates, transmits and distributes electricity; and constructs, operates, and maintains power plants. It uses cl …
  • BioDot Inc-医療機器分野:企業M&A・提携分析
    Summary BioDot Inc (BioDot) is a healthcare products provider that manufactures low volumes of fluids and powder dispensing products. The company offers lateral flow, immunoblots, biojet, airjet, dry chemistry, bio chips, low volume PCR, glucose biosensors, biosensors, polyject and dispo powder disp …
  • Bulova Technologies Group, Inc.:戦略・SWOT・企業財務分析
    Bulova Technologies Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bulova Technologies Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Kalpataru Power Transmission Ltd:企業の戦略・SWOT・財務情報
    Kalpataru Power Transmission Ltd - Strategy, SWOT and Corporate Finance Report Summary Kalpataru Power Transmission Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Direct Conversion AB:企業の戦略的SWOT分析
    Direct Conversion AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • OJSC Dixy Group:企業の戦略・SWOT・財務情報
    OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report Summary OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ittehad Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Ittehad Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Centene Corp (CNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Edge Therapeutics Inc (EDGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • Sumitomo Mitsui Trust Holdings Inc
    Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Swiss Re Group:企業の戦略・SWOT・財務情報
    Swiss Re Group - Strategy, SWOT and Corporate Finance Report Summary Swiss Re Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Gymboree Group, Inc.:企業の戦略的SWOT分析
    Gymboree Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • CIC Insurance Group Limited (CIC):企業の財務・戦略的SWOT分析
    CIC Insurance Group Limited (CIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Hewlett Packard Enterprise Co (HPE):企業の財務・戦略的SWOT分析
    Hewlett Packard Enterprise Co (HPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • LafargeHolcim Ltd. :企業の戦略・SWOT・財務情報
    LafargeHolcim Ltd. - Strategy, SWOT and Corporate Finance Report Summary LafargeHolcim Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bharat Heavy Electricals Ltd:企業の戦略・SWOT・財務分析
    Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Army and Air Force Exchange Service:企業の戦略・SWOT・財務情報
    Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report Summary Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆